About This Episode
Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead.
Zaidoon A. Al-Zubaidy and Shannon Weatherly